Mira Dx was co-founded by Joanne Weidhaas, M.D., Ph.D. and Frank Slack, Ph.D., whose cutting-edge genetic research has unveiled a new class of genetic biomarkers, based on microRNA biology. Our mission is to apply these novel biomarkers to dramatically improve personalized therapy. Our biomarkers are germ-line, and disrupt microRNA target sites. We have been applying these biomarkers to better direct cancer treatments, including radiation, chemotherapy, and newly developing immune therapies. We are able to apply our biomarkers to the daunting problem of toxicity from treatment, which no other set of biomarkers has been able to do. Through worldwide collaborations MiraDx has advanced this class of biomarkers to the forefront of personalized therapy, and has numerous collaborations across both academic and industry. We encourage you to learn more by visiting our website at MiraDx.com, as well as through visiting our sister non-profit, MiraKind, at MiraKind.org.
View Top Employees from MiraDx, Inc.Website | http://www.miradx.com |
Revenue | $5 million |
Employees | 17 (15 on RocketReach) |
Founded | 2010 |
Address | 11600 Wilshire Blvd, Los Angeles, California 90025, US |
Phone | (424) 387-8100 |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Genetics, Health Care |
SIC | SIC Code 73 Companies, SIC Code 738 Companies |
NAICS | NAICS Code 54199 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5419 Companies |
Looking for a particular MiraDx, Inc. employee's phone or email?
The MiraDx, Inc. annual revenue was $5 million in 2024.
Barbara Mignogna-Korus is the COO of MiraDx, Inc..
15 people are employed at MiraDx, Inc..
MiraDx, Inc. is based in Los Angeles, California.
The NAICS codes for MiraDx, Inc. are [54199, 54, 541, 5419].
The SIC codes for MiraDx, Inc. are [73, 738].